As of August 02, , Pharmacyte Biotech Inc had a $ million market capitalization, putting it in the 18th percentile of companies in the Pharmaceuticals. PharmaCyte Biotech (PMCB) reported earnings per share (EPS) of $0, — estimates of $0 by —. In the same quarter last year, PharmaCyte Biotech's earnings per. Aug PM · PharmaCyte Biotech Announces Closing of $Million Public Offering. (Business Wire) % ; Aug PM · PharmaCyte Biotech. The reverse stock split will reduce the number of shares of the Company's outstanding common stock from approximately billion shares to approximately PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for.
News for PharmaCyte Biotech Stock (PMCB) · PharmaCyte Biotech to Participate in H.C. · PharmaCyte Biotech Establishes Month Shelf Life for Clinical Trial. Stock Overview. Symbol. PMCB. Exchange. Nasdaq. Market Cap. m. Last Price. $ Week Range. $ - $ 09/13/ AM EDT. Investor. PharmaCyte Biotech Inc PMCB:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/14/23 · 52 Week Low What was PharmaCyte Biotech's price range in the past 12 months? PharmaCyte Biotech lowest stock price was $ and its highest was $ in the past 12 months. Stock analysis for PharmaCyte Biotech Inc (PMCB:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. PharmaCyte Biotech Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Detailed Stock Quote · Stock Charts · Historical Quotes. PharmaCyte Biotech Inc. (PMCB). $+(+%). Bid: x Ask: Track PharmaCyte Biotech Inc (PMCB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Trade PharmaCyte Biotech, Inc. - PMCB CFD ; Overnight fee time, (UTC) ; Min traded quantity, 1 ; Currency, USD ; Margin, % ; Stock exchange, United States. The current price of PMCB is USD — it has decreased by −% in the past 24 hours. Watch PharmaCyte Biotech, Inc. stock price performance more closely on. PharmaCyte Biotech, Inc. (NasdaqCM:PMCB) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest.
PharmaCyte Biotech NasdaqCM:PMCB Stock Report ; Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 25 Aug, PharmaCyte Biotech's stock loses more than half its value ahead of Nasdaq debut. The shares of PharmaCyte Biotech Inc. plummeted % in premarket trading. PharmaCyte Biotech Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PMCB is experiencing. Discover historical prices for PMCB stock on Yahoo Finance. View daily, weekly or monthly format back to when PharmaCyte Biotech, Inc. stock was issued. The timing of the purchase, the number of shares repurchased, and the prices paid for the shares under the program will depend on general business and market. Discover real-time PharmaCyte Biotech, Inc. Common Stock (PMCB) stock prices, quotes, historical data, news, and Insights for informed trading and. The current price of PMCB is USD — it has decreased by −% in the past 24 hours. Watch PharmaCyte Biotech, Inc. stock price performance more closely on. View the PMCB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PharmaCyte Biotech Inc.
Pharmacyte Biotech Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock Information ; Symbol. Nasdaq:PMCB ; Price. $ ; Change. Detailed Stock Quote · Stock Charts · Historical Quotes. Settings. Columns. Price Data. Open. High. Low. Close. VWAP. The current stock price of PharmaCyte Biotech (PMCB) is $ as of September 11, What is the market cap of PharmaCyte Biotech (PMCB)?. The market. Over the last year, PharmaCyte Biotech shares have traded in a share price range of $ to $ PharmaCyte Biotech currently has 7,, shares.
Logo PharmaCyte Biotech, Inc. PharmaCyte Biotech, Inc. is a biotechnology company. It is focused on developing cellular therapies for cancer, diabetes, and. As of Jun the stock price of PharmaCyte Biotech is $ What is the current market cap of PharmaCyte Biotech? The current market capitalization of. PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and. Technicals Summary. Sell. Neutral. Buy. Pharmacyte Biotech Inc is currently not in a favorable trading position (SELL) according to technical analysis. PharmaCyte Biotech, Inc NASDAQ: PMCB is a biotechnology company focused on developing and preparing to commercialize cellular therapies for cancer.
PharmaCyte Biotech, Inc.